Le Lézard
Classified in: Health
Subject: SVY

Public supports NIH grants for Alzheimer's microbes, reports Alzheimer's Germ Quest, Inc.


NAPLES, Fla., Dec. 18, 2018 /PRNewswire/ -- The public wants to see more research grant money allocated by the National Institutes of Health (NIH) to clarifying whether or not germs play a role in triggering Alzheimer's disease, judging by early results of a national campaign launched three weeks ago, says Leslie Norins, M.D., Ph.D., CEO of Alzheimer's Germ Quest, Inc.

He says hundreds of encouraging messages have been received, but not a single negative comment.

"The big surprise so far is that many people thought NIH already had funded investigations of every possible infectious agent in searching for the unknown trigger of Alzheimer's disease," says Dr. Norins.

But when they find out only a few grants have been made specifically for this purpose they want more funds allocated to it, he says, "especially when they learn the NIH is getting a record $2.3 billion from Congress to dole out for Alzheimer's research."

Dr. Norins says, "Our campaign urges the NIH to allocate to Alzheimer's microbe research $230 million in grants, which is just ten percent of its appropriation. That will still leave them with 90 percent ? a comfortable $2 billion ? to fund traditional Alzheimer's research topics, which as yet haven't yielded a cure or even the root cause."

In a video on the website Dr. Norins conveys the analysis which motivated the campaign.

He adds that grant applications to investigate Alzheimer's microbes are presently given low scores by the NIH evaluation panels because they contain few judges with extensive experience in infectious diseases. "But top officials at NIH could remedy this," he says.

Dr. Norins emphasizes he is not claiming germs definitely are the trigger for Alzheimer's disease, but he says there are many clues suggesting this might be the case. "At least, this possibility must be thoroughly investigated to find out one way or the other," he says.

Alzheimer's Germ quest, Inc is a public benefit corporation headquartered in Naples, Florida. It sponsors the "$1 Million Challenge Award" for the scientist who provides persuasive evidence that a particular infectious agent is the root cause of Alzheimer's disease. The group is self-funded, and neither solicits nor accepts outside donations or grants.

 

SOURCE Alzheimer's Germ Quest, Inc.


These press releases may also interest you

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

at 12:01
Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be five with no deputy board...



News published on and distributed by: